MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

February 2014


Specialty Pharmacy Networks for Hospitals in the Offing

Absence of Onsite Access to Specialty Pharmaceuticals Has Care and Financial Implications

Two competing hospital networks are assembling specialty pharmacy programs to satisfy drug manufacturers’ requirements for delivery of costly, restricted distribution drugs to hospitals. Hospitals’ inability to dispense such drugs can affect patient care and revenue.
Stephen Barlas

Health Care & Law

Implications of Recent Controlled Substance Policy Initiatives

Legislative and regulatory efforts to address controlled substance diversion and overuse of narcotics are affecting prescription drug utilization and patient care. These initiatives can influence formulary drug selection, prior authorization procedures, and drug utilization strategies.
E. Paul Larrat, RPh, PhD; Rita M. Marcoux, RPh, MBA; and F. Randy Vogenberg, RPh, PhD

Drugs That Offer a Survival Advantage for Men With Bone Metastases Resulting From Castration-Resistant Prostate Cancer

New and Emerging Treatment Options

A survival benefit has been demonstrated or is under investigation as the primary outcome among certain recently approved agents and investigational agents for men with metastatic castration-resistant prostate cancer that has spread to bone.
Jack McCain

Meeting Highlights

American Society of Hematology

55th Annual Meeting and Exposition

Topics include pharmacological treatments for sickle-cell disease, myelofibrosis, multiple myeloma, chronic myeloid leukemia, and β-Thalassemia.
Walter Alexander


Medication Errors

Avoiding Patient Harm From a Magnesium Bolus Dose

Matthew Grissinger, RPh, FaScP

Prescription: Washington

Hospitals Have an Extra Year to Meet Stage 2 Meaningful Use Standards

American Hospital Association Wants New Concessions

Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Simeprevir (Olysio) for chronic hepatitis C infection; coagu­lation Factor XIII A-subunit (recombinant) (Tretten) for bleeding prevention in congenital Factor XIII A-subunit deficiency; and umeclidinium and vilanterol inhalation powder (Anoro Ellipta) for chronic obstructive pulmonary disease
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Mipomersen (Kynamro)

A Novel Antisense Oligonucleotide Inhibitor for the Management of Homozygous Familial Hypercholesterolemia

Elaine Wong, PharmD, BCPS; and Tamara Goldberg, PharmD, BCPS